media

Novadip has developed a unique tissue regeneration platform capable of generating multiple product classes to transform the lives of patients with limited or no effective treatment options.

Novadip’s unique “3M³” platform combines over 15 years of academic research with practical surgery experience and proof of principle clinical data to optimise efficacy and safety. The platform is able to generate multiple product classes.